What Does the COVID-19 Pandemic Mean for Rheumatology Patients?
Identifieur interne : 000019 ( PubMed/Checkpoint ); précédent : 000018; suivant : 000020What Does the COVID-19 Pandemic Mean for Rheumatology Patients?
Auteurs : Janet E. PopeSource :
- Current treatment options in rheumatology [ 2198-6002 ] ; 2020.
Abstract
The COVID-19 outbreak has resulted in uncertainty for patients with autoimmune rheumatic diseases for several reasons. They are concerned about their risk of developing COVID-19 as many are immune suppressed from their disease and/or treatment, whether they should stop their advanced therapies, if they will have a worse outcome if/when infected due to their underlying medication condition(s) and if they will have drug availability, especially with press (without much data) coverage suggesting hydroxychloroquine may be used in COVID-19 infection causing diversion of medication supply. This article discusses how the pandemic affects people with systemic autoimmune rheumatic diseases.
DOI: 10.1007/s40674-020-00145-y
PubMed: 32355607
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:32355607Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">What Does the COVID-19 Pandemic Mean for Rheumatology Patients?</title><author><name sortKey="Pope, Janet E" sort="Pope, Janet E" uniqKey="Pope J" first="Janet E" last="Pope">Janet E. Pope</name><affiliation><nlm:affiliation>1Schulich School of Medicine & Dentistry, London, ON Canada.</nlm:affiliation><wicri:noCountry code="subField">ON Canada</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32355607</idno><idno type="pmid">32355607</idno><idno type="doi">10.1007/s40674-020-00145-y</idno><idno type="wicri:Area/PubMed/Corpus">000004</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000004</idno><idno type="wicri:Area/PubMed/Curation">000004</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000004</idno><idno type="wicri:Area/PubMed/Checkpoint">000019</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000019</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">What Does the COVID-19 Pandemic Mean for Rheumatology Patients?</title><author><name sortKey="Pope, Janet E" sort="Pope, Janet E" uniqKey="Pope J" first="Janet E" last="Pope">Janet E. Pope</name><affiliation><nlm:affiliation>1Schulich School of Medicine & Dentistry, London, ON Canada.</nlm:affiliation><wicri:noCountry code="subField">ON Canada</wicri:noCountry></affiliation></author></analytic><series><title level="j">Current treatment options in rheumatology</title><idno type="ISSN">2198-6002</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The COVID-19 outbreak has resulted in uncertainty for patients with autoimmune rheumatic diseases for several reasons. They are concerned about their risk of developing COVID-19 as many are immune suppressed from their disease and/or treatment, whether they should stop their advanced therapies, if they will have a worse outcome if/when infected due to their underlying medication condition(s) and if they will have drug availability, especially with press (without much data) coverage suggesting hydroxychloroquine may be used in COVID-19 infection causing diversion of medication supply. This article discusses how the pandemic affects people with systemic autoimmune rheumatic diseases.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32355607</PMID><DateRevised><Year>2020</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2198-6002</ISSN><JournalIssue CitedMedium="Print"><PubDate><Year>2020</Year><Month>Apr</Month><Day>30</Day></PubDate></JournalIssue><Title>Current treatment options in rheumatology</Title><ISOAbbreviation>Curr Treatm Opt Rheumatol</ISOAbbreviation></Journal><ArticleTitle>What Does the COVID-19 Pandemic Mean for Rheumatology Patients?</ArticleTitle><Pagination><MedlinePgn>1-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40674-020-00145-y</ELocationID><Abstract><AbstractText Label="Purpose of review" NlmCategory="UNASSIGNED">The COVID-19 outbreak has resulted in uncertainty for patients with autoimmune rheumatic diseases for several reasons. They are concerned about their risk of developing COVID-19 as many are immune suppressed from their disease and/or treatment, whether they should stop their advanced therapies, if they will have a worse outcome if/when infected due to their underlying medication condition(s) and if they will have drug availability, especially with press (without much data) coverage suggesting hydroxychloroquine may be used in COVID-19 infection causing diversion of medication supply. This article discusses how the pandemic affects people with systemic autoimmune rheumatic diseases.</AbstractText><AbstractText Label="Recent findings" NlmCategory="UNASSIGNED">Preliminarily, articles seem to suggest that patients with rheumatic diseases may not have more infections from SARS-CoV-2 and similar outcomes to age and gender matched patients, but fear of rheumatic medications increasing their risk, drug shortages, and work exposure all are concerns for patients.</AbstractText><AbstractText Label="Recent findings" NlmCategory="UNASSIGNED">The long term effects of the pandemic in patients with rheumatic diseases will not be known until much later and likely include stressors flaring disease (fear, illness, job loss, social isolation), post-traumatic stress, flaring due to stopping medications, less physician visits with subsequent under-treatment, and increases in chronic concomitant fatigue, pain, fibromyalgia.</AbstractText><CopyrightInformation>© Springer Nature Switzerland AG 2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pope</LastName><ForeName>Janet E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>1Schulich School of Medicine & Dentistry, London, ON Canada.</Affiliation><Identifier Source="GRID">grid.39381.30</Identifier><Identifier Source="ISNI">0000 0004 1936 8884</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>2Western University, London, ON Canada.</Affiliation><Identifier Source="GRID">grid.39381.30</Identifier><Identifier Source="ISNI">0000 0004 1936 8884</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>3Department of Medicine, Division of Rheumatology, St Joseph's Health Care, 268 Grosvenor St., London, ON N6A 4V2 Canada.</Affiliation><Identifier Source="GRID">grid.416448.b</Identifier><Identifier Source="ISNI">0000 0000 9674 4717</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Curr Treatm Opt Rheumatol</MedlineTA><NlmUniqueID>101649954</NlmUniqueID><ISSNLinking>2198-6002</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">Drug shortages</Keyword><Keyword MajorTopicYN="N">Pandemic</Keyword><Keyword MajorTopicYN="N">Rheumatologists</Keyword><Keyword MajorTopicYN="N">Rheumatology</Keyword></KeywordList><CoiStatement>Conflict of InterestThe author declares that she has no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32355607</ArticleId><ArticleId IdType="doi">10.1007/s40674-020-00145-y</ArticleId><ArticleId IdType="pii">145</ArticleId><ArticleId IdType="pmc">PMC7191545</ArticleId></ArticleIdList><pmc-dir>pmcsd</pmc-dir>
</PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Pope, Janet E" sort="Pope, Janet E" uniqKey="Pope J" first="Janet E" last="Pope">Janet E. Pope</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000019 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000019 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:32355607
|texte= What Does the COVID-19 Pandemic Mean for Rheumatology Patients?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:32355607" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a StressCovidV1
| This area was generated with Dilib version V0.6.33. |  |